BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2459619)

  • 1. Immunogenicity of different types of interferons in the treatment of hairy-cell leukemia.
    von Wussow P; Freund M; Dahle S; Jakschies D; Poliwode H; Deicher H
    N Engl J Med; 1988 Nov; 319(18):1226-7. PubMed ID: 2459619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferons and hairy cell leukemia].
    Boiron M
    Pathol Biol (Paris); 1989 Mar; 37(3):185-7. PubMed ID: 2471133
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferons. Basic principles and use in clinic and general practice].
    Hündgen M; von Eick H
    Med Monatsschr Pharm; 1991 Jun; 14(6):164-73. PubMed ID: 1714536
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and biological activity of the interferons in hematologic malignancies.
    Gutterman JU
    Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon and its use for treating hairy cell leukemia].
    Markov V
    Vutr Boles; 1990; 29(3):34-40. PubMed ID: 1704666
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in the treatment of hairy-cell leukemia.
    Golomb HM; Ratain MJ
    N Engl J Med; 1987 Apr; 316(14):870-2. PubMed ID: 2434851
    [No Abstract]   [Full Text] [Related]  

  • 7. The biology of hairy cell leukemia. A study of the practical aspects of interferon-treatment, its mechanism of action and on the pathogenesis of anemia.
    Nielsen B
    APMIS Suppl; 1995; 52():1-39. PubMed ID: 7576791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic aspects of hairy cell leukemia].
    Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R
    Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].
    Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G
    Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferons in the treatment of hematological diseases].
    Jantunen E; Nousiainen T
    Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
    [No Abstract]   [Full Text] [Related]  

  • 11. Hairy cell leukemia: the Italian Cooperative Group experience.
    Federico M; Frassoldati A; Lamparelli T; Dini E; Resegotti L; Damasio EE
    Leukemia; 1992 Nov; 6 Suppl 4():147-8. PubMed ID: 1279328
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hairy cell leukemia: clinical course, prognostic factors and therapy].
    Hofmann V
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):427-9. PubMed ID: 2421385
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotherapy in clinical practice.
    Figlin RA
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferons and interferon therapy].
    Strander H
    Nord Med; 1992; 107(3):70-1. PubMed ID: 1372403
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential treatment of hairy cell leukemia: a new role for interferon.
    Golomb HM; Ratain MJ; Vardiman JW
    Important Adv Oncol; 1986; ():311-21. PubMed ID: 2454218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons as anticancer agents.
    Brodsky I; Hubbell HR
    Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
    Steis RG; Smith JW; Urba WJ; Clark JW; Itri LM; Evans LM; Schoenberger C; Longo DL
    N Engl J Med; 1988 Jun; 318(22):1409-13. PubMed ID: 3367950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotherapy with interferon in hematologic malignancies.
    Roth MS; Foon KA
    Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and mechanisms of interferon resistance.
    Kloke O; Niederle N
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.